Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts

Evidence-based Complementary and Alternative Medicine

Volumn 3, Issue 3, 2006, Pages 317-327

  Samane, Samira ^a,b,c   Noël, Josette ^a   Charrouf, Zoubida ^d   Amarouch, Hamid ^c   Haddad, Pierre Selim ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c HASSAN II UNIVERSITY   (Morocco)

^d MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Cancer; Diabetes; MAPK; PKB; Transformed cell lines

Indexed keywords

ARGANIA SPINOSA EXTRACT; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLANT EXTRACT; PROTEIN KINASE B; SAPONIN; UNCLASSIFIED DRUG; VEGETABLE OIL;

ANIMAL CELL; ARGANIA SPINOSA; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; FRUIT; HEPATOMA CELL; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LOW DRUG DOSE; MEDICINAL PLANT; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 33748210066     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nel015     Document Type: Article

References (52)

1. Charrouf Z, Guillaume D. Chemistry of the secondary metabolites of Argania spinosa (L.) skeels. Curr Topics Phytochem 2002a;5:99-102.
2. Charrouf Z, Guillaume D. Ethnoeconomical, ethnomedical, and phytochemical study of Argania spinosa (L.) Skeels. J Ethnopharmacol 1999;67:7-14.
3. Berrada Y, Settaf A, Baddouri K, Cherrah A, Hassar M. Experimental evidence of an antihypertensive and hypocholesterolemic effect of oil of argan, Argania sideroxylon. Therapie 2000;55:375-8.
4. Berrougui H, Ettaib A, Herrera Gonzalez MD, Alvarez de Sotomayor M, Benna-Kabchi N, et al. Hypolipidemic and hypocholesterolemic effect of argan oil (Argania spinosa L.) in Meriones shawi rats. J Ethnopharmacol 2003;89:15-18.
5. Drissi A, Girona J, Cherki M, Godas G, Derouiche A, El Messal M, et al. Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (Argania spinosa). Clin Nutr 2004;23:1159-66.
6. Alaoui K, Lagorce JF, Cherrah Y, Hassar M, Amarouch H, Roquebert J. Analgesic and anti-inflammatory activity of saponins of Argania spinoza. Ann Pharm Fr 1998b;56:220-8.
7. Chimi H, Cillard J, Cillard P. Autoxydation dec l'huile d'argan (Argania spinosa) sapotacée du Maroc. Sciences des Aliments 1994;14:117-24.
8. Khallouki F, Younos C, Soulimani R, Oster T, Charrouf Z, Spiegelhalder B, et al. Consumption of argan oil (Morocco) with its unique profile of fatty acids, tocopherols, squalene, sterols and phenolic compounds should confer valuable cancer chemopreventive effects. Eur J Cancer Prev 2003;12:67-75.
9. Farines M, Charrouf M, Soulier J, Cave A. Etude de l'huile des graines d'Argania spinosa (L.) Sapotacea. II- Stérols, alcools triterpéniques et méthystérols de l'huile d'argan. Rev Franç Corps Gras 1984;31:443-8.
10. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
11. Capeau J. Insulin signaling: mechanisms altered in insulin resistance. Med Sci (Paris) 2003;19:834-9.
12. Alaoui A, Charrouf Z, Soufiaoui M, Carbone V, Malorni A, Pizza C, et al. Triterpenoid saponins from the shells of Argania spinosa seeds. J Agric Food Chem 2002;50:4600-3.
13. Charrouf Z, Wieruszeski JM, Fkih-Tetouani S, Leroy Y, Charrouf M, Fournet B. Triterpenoid saponins from Argania spinosa. Phytochemistry 1992;29:2629-35.
14. Haddad PS, Vallerand D, Mathe L, Benzeroual K, Van de Werve G. Synergistic activation of mitogen-activated protein kinase by insulin and adenosine triphosphate in liver cells: permissive role of Ca2+. Metabolism 2003;52:590-8.
15. Lidofsky SD, Xie MH, Sostman A, Scharschmidt BF, Fitz JG. Vasopressin increases cytosolic sodium concentration in hepatocytes and activates calcium influx through cation-selective channels. J Biol Chem 1993;268:14632-6.
16. Le PU, Nguyen TN, Drolet-Savoie P, Leclerc N, Nabi IR. Increased beta-actin expression in an invasive moloney sarcoma virus-transformed MDCK cell variant concentrates to the tips of multiple pseudopodia. Cancer Res 1998;58:1631-5.
17. Vadnais J, Nault G, Daher Z, Amraei M, Dodier Y, Nabi IR, et al. Autocrine activation of the hepatocyte growth factor receptor/met tyrosine kinase induces tumor cell motility by regulating pseudopodial protrusion. J Biol Chem 2002;277:48342-50.
18. Carlsen J, Christiansen K, Vinten J. Insulin stimulated Glycogen synthesis in isolated rat hepatocytes: Effet of protein kinase inhibitors. Cell Signal 1997;9:447-50.
19. Alaoui K, Belabbes M, Cherrah Y, Hassar M, Charrouf Z, Amarouch H, et al. Acute and chronic toxicity of saponins from Argania spinosa. Ann Pharm Fr 1998a;56:213-9.
20. Yoshikawa M, Matsuda H. Antidiabetogenic activity of oleanolic acid glycosides from medicinal foodstuffs. Biofactors 2000;13:231-7.
21. Matsuda H, Li Y, Murakami T, Matsumura N, Yamahara J, Yoshikawa M. Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chem Pharm Bull (Tokyo) 1998;46:1399-403.
22. Matsuda H, Li Y, Murakami T, Yamahara J, Yoshikawa M. Structure-related inhibitory activity of oleanolic acid glycosides on gastric emptying in mice. Bioorg Med Chem 1999;7:323-7.
23. Matsuda H, Murakami T, Shimada H, Matsumura N, Yoshikawa M, Yamahara J. Inhibitory mechanisms of oleanolic acid 3-O-monodesmosides on glucose absorption in rats. Biol Pharm Bull 1997;20:717-9.
24. Chimi H, Rahmani M, Cillard P. Etude de la fraction phenolique des huiles d'olives vierges et d'argan du Maroc. Actes de l'institut agronomique et vétérinaire 1988;8:17-22.
25. Charrouf Z, Guillaume D. Secondary metabolites from Argania spinosa (L.) Skeels. Phytochem Rev 2002b;1:345-54.
26. Khallouki F, Spiegelhalder B, Bartsch H, Owen RW. Secondary metabolites ofargan tree (Morocco) may have disease prevention properties. Afr. J. Boitechnol 2005;4:381-88.
27. Harmon AW, Patel YM. Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res Treat 2004;85:103-10.
28. Miyata Y, Sato T, Yano M, Ito A. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin. Mol Cancer Ther 2004;3:839-47.
29. Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 1999;20:2209-18.
30. Bartsch H, Nair J, Owen RW. Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: potential role of lipid peroxidation, dietary fat and antioxidants. Biol Chem 2002;383:915-21.
31. Reiners JJ Jr, Lee JY, Clift RE, Dudley DT, Myrand SP. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol Pharmacol 1998;53:438-45.
32. Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, et al. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res 2004;6:R63-R74.
33. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A 1997;94:3217-22.
34. Gysin R, Azzi A, Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. Faseb J 2002;16:1952-4.
35. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A 2000;97:11494-9.
36. Shklar G, Oh SK. Experimental basis for cancer prevention by vitamin E. Cancer Invest 2000;18:214-22.
37. Wu Y, Zu K, Ni J, Yeh S, Kasi D, James NS, et al. Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention. Anticancer Res 2004;24:3795-802.
38. Clement SA, Tan CC, Guo J, Kitta K, Suzuki YJ. Roles of protein kinase C and alpha-tocopherol in regulation of signal transduction for GATA-4 phosphorylation in HL-1 cardiac muscle cells. Free Radic Biol Med 2002;32:341-9.
39. Arizawa M, Kinghom A, Cordell G, Phebec C, Fansworth N. Plant anticancer agents: schottenol glucosides from Bacharis cordifolia and Ipnosis aggregatta. Planta medica 1985;6:544-5.
40. Iwatsuki K, Akihisa T, Tokuda H, Ukiya M, Higashihara H, Mukainaka T, et al. Sterol ferulates, sterols, and 5-alk(en)ylresorcinols from wheat, rye, and corn bran oils and their inhibitory effects on Epstein-Barr virus activation. J Agric Food Chem 2003;51:6683-8.
41. Jeon GC, Park MS, Yoon DY, Shin CH, Sin HS, Um SJ. Antitumor activity of spinasterol isolated from Pueraria roots. Exp Mol Med 2005;37:111-20.
42. Villasenor IM, Domingo AP. Anticarcinogenicity potential of spinasterol isolated from squash flowers. Teratog Carcinog Mutagen 2000;20:99-105.
43. Jeong SI, Kim KJ, Choi MK, Keum KS, Lee S, Ahn SH, et al. alpha-Spinasterol isolated from the root of Phytolacca americana and its pharmacological property on diabetic nephropathy. Planta Med 2004;70:736-9.
44. Saleem M, Afaq F, Adhami VM, Mukhtar H. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004;23:5203-14.
45. Saleem M, Kaur S, Kweon MH, Adhami VM, Afaq F, Mukhtar H. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. Carcinogenesis 2006; in press.
46. Chan P, Tomlinson B, Lee CB, Lee YS. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia. J Clin Pharmacol 1996;36:422-7.
47. Rao CV, Newmark HL, Reddy BS. Chemopreventive effect of squalene on colon cancer. Carcinogenesis 1998;19:287-90.
48. Newmark HL. Squalene, olive oil, and cancer risk: a review and hypothesis. Cancer Epidemiol Biomarkers Prev 1997;6:1101-3.
49. Das B, Yeger H, Baruchel H, Freedman MH, Koren G, Baruchel S. In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity. implications in cancer chemotherapy. Eur J Cancer 2003;39:2556-65.
50. Kohl NE, Conner MW, Gibbs JB, Graham SL, Hartman GD, Oliff A. Development of inhibitors of protein farnesylation as potential chemotherapeutic agents. J Cell Biochem Suppl 1995;22:145-50.
51. Haddad PS, Azar GA, Groom S, Boivin M. Natural Health Products, Modulation of immune function and preventaion of chronic diseases. Evidence-based Complem. Altern. Med. 2005;2:513-20.
52. Haddad PS, Beauchamp G, Côté G, Boivin M. Maintenance of an efficient and equilibrated immune system through the novel use of natural health products: synopsis of a symphosium. Evidence-based Complem. Altern. Med. 2005;2:237-8.